Data / Crowdfunding / VITA IMAGING INC.
VITA IMAGING INC.: crowdfunding raise on PicMii Crowdfunding LLC, $9,997 to $3,804,014 (2026)
VITA IMAGING INC., a company, filed a Form C with the SEC on July 13, 2026 to raise $9,997 to $3,804,014 in common stock through PicMii Crowdfunding LLC. The offering closed on October 30, 2026. In its most recent fiscal year it reported $0 in revenue and a net loss of $1,836,387, with 50 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- www.vita-imaging.com
- Funding portal
- PicMii Crowdfunding LLC
- SEC CIK
- 0001804181
Offering terms
From the amendment filed July 13, 2026.
- Security
- Common Stock
- Price
- $5.70
- Target
- $9,997
- Maximum
- $3,804,014
- Deadline
- October 30, 2026
- Portal compensation
- Intermediary will receive cash compensation equal to 4.9% of the value of the securities sold through Regulation CF and will be compensated with out-of-pocket expenses to set up the offering.
Financials
From the Form C/A filed July 13, 2026.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $0 | $0 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-1,836,387 | $-1,106,278 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $607,842 | $583,376 | sec.gov |
| Cash | $36,257 | $32,261 | sec.gov |
| Accounts receivable | $24,079 | $17,547 | sec.gov |
| Short-term debt | $1,106,215 | $660,161 | sec.gov |
| Long-term debt | $2,124,036 | $1,575,766 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| October 2, 2026 | Withdrawal | Not listed | Not listed | sec.gov | ||
| July 13, 2026 | Amendment | $9,997 | $3,804,014 | October 30, 2026 | Issuer Updated their valuation. | sec.gov |
| July 10, 2026 | Offering | $9,997 | $3,804,014 | October 30, 2026 | sec.gov | |
| July 9, 2026 | Annual report | Not listed | Not listed | sec.gov | ||
| February 5, 2026 | Progress update | $19,995 | $4,145,678 | October 20, 2025 | At the close of the offering, the issuer closed on $330,604.00 and 73,098 number of securities. | sec.gov |
| December 12, 2025 | Amendment | $19,995 | $4,145,678 | February 3, 2026 | Offering is being extended to February 3, 2026. | sec.gov |
| October 16, 2025 | Amendment | $19,995 | $4,145,678 | December 19, 2025 | Offering is being extended to December 19, 2025 | sec.gov |
| July 23, 2025 | Offering | $19,995 | $4,145,678 | October 20, 2025 | sec.gov | |
| May 16, 2025 | Offering | $50,000 | $1,846,800 | April 30, 2026 | sec.gov | |
| April 29, 2025 | Annual report | Not listed | Not listed | sec.gov | ||
| March 25, 2025 | Progress update | $15,002 | $3,811,048 | March 13, 2025 | The issuer has closed on $815,591.05 and 211,392 shares. | sec.gov |
| January 24, 2025 | Amendment | $15,002 | $3,811,048 | March 13, 2025 | Issuer is updating their campaignpage. | sec.gov |
| December 17, 2024 | Amendment | $15,002 | $3,811,048 | March 13, 2025 | Issuer is updating their campaign end date to March 13th, 2025. | sec.gov |
| December 2, 2024 | Annual report, amended | Not listed | Not listed | sec.gov | ||
| October 29, 2024 | Amendment | $15,002 | $3,811,048 | January 13, 2025 | Issuer is updating their campaign end date to January 13th, 2025 and is updating their campaign page. | sec.gov |
| August 12, 2024 | Offering | $15,002 | $3,811,048 | November 11, 2024 | sec.gov | |
| July 5, 2024 | Progress update | $15,000 | $4,120,000 | August 26, 2024 | The issuer closed the offering on June 28, 2024. At the close of the offering, the issuer closed on $360,854.30 and 70,313 number of securities. | sec.gov |
| April 26, 2024 | Annual report | Not listed | Not listed | sec.gov | ||
| April 26, 2024 | Amendment | $15,000 | $4,120,000 | August 26, 2024 | We have extended the Offering until August 26, 2024, completed audited financial statements for the years ended December 31, 2022, and 2023, and extended our timeline to meet additional FDA medical device regulatory requirements. | sec.gov |
| March 12, 2024 | Amendment | $15,000 | $4,120,000 | April 29, 2024 | The Issuer has extended the 10% Time Based Bonus until 11:59 p.m. Pacific Time on March 25, 2024. | sec.gov |
| February 27, 2024 | Offering | $15,000 | $4,120,000 | April 29, 2024 | sec.gov | |
| November 22, 2023 | Progress update | $14,996 | $4,999,994 | November 13, 2023 | At the close of the offering, the issuer closed on $755,325.72 and 141,943 number of securities. | sec.gov |
| September 8, 2023 | Amendment | $14,996 | $4,999,994 | November 13, 2023 | Issuer is extending their campaign end date | sec.gov |
| July 7, 2023 | Amendment | $14,996 | $4,999,994 | September 14, 2023 | Issuer is extending their campaign end date | sec.gov |
| May 17, 2023 | Offering | $14,996 | $4,999,994 | July 16, 2023 | sec.gov |
Updated October 2, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.